Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BFLY Butterfly Network	$2.30 -3.4%	$2.40	$0.82 ▼ $4.98	$568.77M	2.59	2.91 million shs	1.93 million shs
KIDS OrthoPediatrics	$22.85 -1.6%	$22.94	$20.25 ▼ $35.99	$554.96M	1.09	196,688 shs	141,908 shs
LUNG Pulmonx	$3.26 -1.8%	$5.66	$3.18 ▼ $9.41	$131.24M	0.65	311,721 shs	391,454 shs
RXST RxSight	$13.24 +0.3%	$18.54	$12.54 ▼ $64.50	$538.03M	1.32	667,592 shs	1.15 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BFLY Butterfly Network	+1.49%	+9.93%	-2.66%	-45.16%	+150.00%
KIDS OrthoPediatrics	-0.26%	+8.31%	+9.69%	-6.82%	-25.44%
LUNG Pulmonx	-9.78%	-3.21%	-36.76%	-52.64%	-62.14%
RXST RxSight	-4.00%	-5.38%	-6.25%	-58.62%	-77.55%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BFLY Butterfly Network	2.6299 of 5 stars	3.5	3.0	0.0	1.9	2.5	0.6
KIDS OrthoPediatrics	4.541 of 5 stars	4.4	1.0	3.9	2.5	4.2	0.6
LUNG Pulmonx	3.7033 of 5 stars	4.4	3.0	0.0	3.6	2.5	0.6
RXST RxSight	2.812 of 5 stars	4.1	1.0	0.0	2.8	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BFLY Butterfly Network	3.00	Buy	$4.00	73.91% Upside
KIDS OrthoPediatrics	2.83	Moderate Buy	$35.83	56.82% Upside
LUNG Pulmonx	2.78	Moderate Buy	$12.07	270.29% Upside
RXST RxSight	2.20	Hold	$37.60	183.99% Upside

Current Analyst Ratings Breakdown

Latest LUNG, BFLY, KIDS, and RXST Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/8/2025	KIDS OrthoPediatrics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$40.00 ➝ $30.00
5/8/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
5/5/2025	BFLY Butterfly Network	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.00 ➝ $4.00
5/1/2025	LUNG Pulmonx	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$16.00 ➝ $15.00
5/1/2025	LUNG Pulmonx	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$10.00 ➝ $9.00
5/1/2025	LUNG Pulmonx	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$17.00 ➝ $17.00
4/15/2025	RXST RxSight	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$18.00
4/11/2025	KIDS OrthoPediatrics	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$26.00 ➝ $24.00
4/9/2025	KIDS OrthoPediatrics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$42.00 ➝ $42.00
4/9/2025	RXST RxSight	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$45.00 ➝ $16.00
4/7/2025	KIDS OrthoPediatrics	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$37.00

(Data available from 5/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BFLY Butterfly Network	$85.63M	6.64	N/A	N/A	$1.06 per share	2.17
KIDS OrthoPediatrics	$212.45M	2.61	N/A	N/A	$16.14 per share	1.42
LUNG Pulmonx	$87.47M	1.50	N/A	N/A	$3.09 per share	1.06
RXST RxSight	$148.31M	3.63	N/A	N/A	$4.47 per share	2.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BFLY Butterfly Network	-$133.70M	-$0.29	N/A	N/A	N/A	-129.25%	-42.68%	-30.31%	N/A
KIDS OrthoPediatrics	-$20.97M	-$1.75	N/A	N/A	N/A	-15.00%	-5.78%	-4.80%	N/A
LUNG Pulmonx	-$60.84M	-$1.44	N/A	N/A	N/A	-67.31%	-55.36%	-33.53%	7/29/2025 (Estimated)
RXST RxSight	-$48.61M	-$0.67	N/A	N/A	N/A	-23.92%	-14.00%	-12.51%	N/A

Latest LUNG, BFLY, KIDS, and RXST Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2025	Q1 2025	KIDS OrthoPediatrics	-$0.26	-$0.39	-$0.13	-$0.46	$51.68 million	$52.41 million
5/7/2025	Q1 2025	LUNG Pulmonx	-$0.37	-$0.36	+$0.01	-$0.36	$22.03 million	$22.54 million
5/7/2025	Q1 2025	RXST RxSight	-$0.03	-$0.03	N/A	-$0.20	$38.74 million	$37.90 million
5/2/2025	Q1 2025	BFLY Butterfly Network	-$0.09	-$0.06	+$0.03	-$0.06	$21.16 million	$21.23 million
3/4/2025	Q4 2024	KIDS OrthoPediatrics	-$0.33	-$0.29	+$0.04	-$0.69	$51.16 million	$52.67 million
2/25/2025	Q4 2024	RXST RxSight	$0.10	-$0.15	-$0.25	-$0.15	$40.23 million	$40.21 million
2/19/2025	Q4 2024	LUNG Pulmonx	-$0.45	-$0.33	+$0.12	-$0.33	$22.29 million	$23.77 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BFLY Butterfly Network	N/A	N/A	N/A	N/A	N/A
KIDS OrthoPediatrics	N/A	N/A	N/A	N/A	N/A
LUNG Pulmonx	N/A	N/A	N/A	N/A	N/A
RXST RxSight	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BFLY Butterfly Network	N/A	4.66	2.95
KIDS OrthoPediatrics	0.19	7.17	3.68
LUNG Pulmonx	0.40	7.70	6.77
RXST RxSight	N/A	12.67	11.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BFLY Butterfly Network	37.85%
KIDS OrthoPediatrics	69.05%
LUNG Pulmonx	91.04%
RXST RxSight	78.78%

Insider Ownership

Company	Insider Ownership
BFLY Butterfly Network	27.28%
KIDS OrthoPediatrics	32.70%
LUNG Pulmonx	6.80%
RXST RxSight	9.36%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BFLY Butterfly Network	460	247.29 million	154.94 million	Optionable
KIDS OrthoPediatrics	200	24.29 million	16.52 million	Optionable
LUNG Pulmonx	250	40.26 million	37.24 million	Optionable
RXST RxSight	220	40.64 million	36.53 million	Optionable

LUNG, BFLY, KIDS, and RXST Headlines

Recent News About These Companies

Voya Investment Management LLC Sells 70,274 Shares of RxSight, Inc. (NASDAQ:RXST)

May 12 at 3:44 AM | marketbeat.com

Dimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST)

May 12 at 3:26 AM | marketbeat.com

RxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target Price

May 10, 2025 | finance.yahoo.com

Cubist Systematic Strategies LLC Buys 151,358 Shares of RxSight, Inc. (NASDAQ:RXST)

May 10, 2025 | marketbeat.com

RxSight, Inc. (NASDAQ:RXST) Shares Purchased by Algert Global LLC

May 10, 2025 | marketbeat.com

RxSight (NASDAQ:RXST) Reaches New 52-Week Low After Earnings Miss

May 10, 2025 | americanbankingnews.com

Earnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67%

May 9, 2025 | investing.com

RxSight, Inc. Reports 28% Revenue Growth in Q1 2025, Highlights Strong Demand for Light Adjustable Lenses

May 9, 2025 | nasdaq.com

Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

May 9, 2025 | benzinga.com

RxSight, Inc. (NASDAQ:RXST) Shares Sold by First Trust Advisors LP

May 9, 2025 | marketbeat.com

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ...

May 8, 2025 | finance.yahoo.com

RxSight, Inc. Reports Strong Q1 2025 Revenue Growth

May 8, 2025 | tipranks.com

RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript

May 7, 2025 | seekingalpha.com

RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

May 7, 2025 | zacks.com

RxSight, Inc. Reports First Quarter 2025 Financial Results

May 7, 2025 | finance.yahoo.com

RxSight (NASDAQ:RXST) Trading Down 6.1% - Here's What Happened

May 7, 2025 | marketbeat.com

RxSight’s Earnings Call: Growth Amid Challenges

May 6, 2025 | tipranks.com

Tudor Investment Corp ET AL Purchases 36,669 Shares of RxSight, Inc. (NASDAQ:RXST)

May 6, 2025 | marketbeat.com

RxSight (RXST) Projected to Post Earnings on Wednesday

May 5, 2025 | americanbankingnews.com

4D Advisors LLC Takes $1.89 Million Position in RxSight, Inc. (NASDAQ:RXST)

May 4, 2025 | marketbeat.com

Schonfeld Strategic Advisors LLC Takes Position in RxSight, Inc. (NASDAQ:RXST)

May 4, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?
By Jeffrey Neal Johnson | April 25, 2025
View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?
Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
By Nathan Reiff | April 30, 2025
View Why D-Wave's Project With Davidson Is a Game-Changer For Quantum
Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit
By Chris Markoch | April 16, 2025
View Gold Rally Continues: These 3 Mining Stocks Are Likely to Benefit
2 Smart Investments to Follow Warren Buffett’s Lead
By Ryan Hasson | April 23, 2025
View 2 Smart Investments to Follow Warren Buffett’s Lead
PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy
By Thomas Hughes | April 28, 2025
View PepsiCo’s Stock Price is Disconnected From Reality: Time to Buy

LUNG, BFLY, KIDS, and RXST Company Descriptions

Butterfly Network NYSE:BFLY

$2.30 -0.08 (-3.36%)

As of 03:48 PM Eastern

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

OrthoPediatrics NASDAQ:KIDS

$22.85 -0.36 (-1.55%)

As of 04:00 PM Eastern

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Pulmonx NASDAQ:LUNG

$3.26 -0.06 (-1.81%)

As of 04:00 PM Eastern

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

RxSight NASDAQ:RXST

$13.24 +0.04 (+0.30%)

As of 04:00 PM Eastern

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time